Popular Stories

Hypertension Tag

  • All
  • Biotechnology
  • Cannabis
  • Education
  • Energy
  • Investing Ideas
  • Macro
  • Miscellaneous
  • Sectors
  • Startups
  • Technologies
  • Trending
  • Uncategorized
5 AI Stocks to Watch in 2021

While Industries across the globe are grappling with the pandemic and its impact on their operations, Technology Industry has been focused on minimizing the impact and marching ahead with its innovations and breakthroughs, be it healthcare, contactless payments or big data analysis. Artificial Intelligence is witnessing...

ChromaDex Seeking to Redefine Its “Anti-Aging” Pill Persona

ChromaDex (NASDAQ: CDXC), a nutraceutical Company focussed on improving the way people age, announced the launch of a “first-of-its-kind” Phase 1 clinical study to test the safety, efficacy and potential of branded nicotinamide riboside (NR), Niagen, in improving the effects of exercise therapy in older...

Cyclerion Therapeutics Praliciguat Fails in Two Crucial Clinical Trials

Cyclerion Therapeutics (NASDAQ: CYCN), a clinical-stage Company, announced the failure of its drug candidate praliciguat in meeting the primary endpoints in two separate clinical studies, in diabetic nephropathy (DN) and heart failure with preserved ejection fraction (HFpEF). Praliciguat is a soluble guanylate cyclase (sGC) stimulator...

A Cure for Narcolepsy No Longer a Pipe-Dream!

Narcolepsy is a sleep disorder that affects 1 in 2000 individuals and is caused by the loss or damage of a chemical named Hypocretin present in the hypothalamus, which is responsible for the regulation of sleep cycles and alerting the brain. This disorder is characterized...

WordPress Video Lightbox Plugin